Reader-supported. We may earn a commission when you use our partner links. How we’re funded
Our take
The format choice is Strut’s main appeal. Its $99 lozenge may look like the easier, cheaper option beside the $119 injection, but I would not choose between them on price alone: they are different formulations with different evidence questions.
What stands out
- Separate injection and lozenge prices published
- Physician consultations and shipping included
- Follow-up care and provider messaging advertised
What to weigh
- Advertised pricing uses auto-refill
- Final pricing is determined after consultation
- A lozenge should not be assumed equivalent to an injection
What Strut Health offers
Strut Health offers compounded sermorelin as an injection and a sublingual lozenge. Its pricing section lists $119 for a monthly injection vial and $99 for a 30-day oral supply. The page describes the offering as auto-refill, with final pricing determined after consultation.
The lozenge is the obvious point of interest for someone reluctant to use needles. Having that option is useful, but an easier routine only helps if the formulation makes sense for the treatment goal.
I like that Strut puts a separate price beside each format. It gives readers something concrete to compare. My reservation is that those figures still leave the prescribed dose, final recurring bill, and dispensing pharmacy to be confirmed.
What is included—and what renews
Strut says physician consultations and free shipping are included in the advertised price. The page also advertises free follow-up care and messaging access to the provider.
These are auto-refill prices, so the renewal terms are part of the purchase. I would want the billing date, refill processing date, and cancellation deadline in writing. “Cancel anytime” does not tell you whether an already processed prescription is refundable.
The $99 oral supply costs $20 less than the advertised injection at Strut. This is a price comparison between different formulations, not a cost comparison between equivalent clinical results.
Injection or lozenge?
Strut describes the oral option as a sublingual lozenge and lists a 30-day supply. Its injection is administered under the skin. The website describes different administration routines, but your own prescription and pharmacy instructions should determine how you use a dispensed medication.
Ask the clinician for evidence relevant to the chosen route. An ingredient shared by two preparations is not enough to establish equal absorption or outcomes. Do not convert doses between formats yourself.
For travel or day-to-day convenience, clarify storage and handling before ordering. The right question is not simply which format is easier, but which—if either—is appropriate for the clinical goal.
From questionnaire to prescription
The published process begins with a health questionnaire, followed by physician review and a treatment plan if appropriate. Medication is then shipped through the provider’s fulfillment process. Approval is not guaranteed.
Messaging and free follow-ups could make ongoing care more convenient. The details to settle are state availability, the dispensing pharmacy, and how to arrange a follow-up when you need one.
Safety and the limits of this review
Strut discloses that compounded medications are not FDA-approved and that the FDA has not evaluated them for safety, effectiveness, or quality. Its safety information is a useful starting point for discussion with a clinician, not a substitute for your own evaluation.
Strut’s page advertises possible benefits for sleep, recovery, and vitality. This review does not verify those outcomes or rank Strut by medical effectiveness. Our evidence guide explains why a mechanism is not the same as a demonstrated benefit.
We have not used Strut as a patient, ordered or tested its medication, or inspected its dispensing pharmacies. This is a research-based assessment of the published offer.
Regulatory context
FDA issued Strut Health a warning letter in February 2026 about misleading marketing of compounded semaglutide and tirzepatide, including representations about the compounder and FDA evaluation. The letter concerns those GLP-1 products; it is not a finding that Strut’s sermorelin is contaminated or ineffective.
This is relevant company context when evaluating how a provider communicates about compounded drugs. The FDA letter describes FDA’s concerns at that time; we have not established a subsequent resolution.
Where Strut fits
Strut makes the most sense on a shortlist for readers weighing both formats and looking for consultations and shipping in the advertised price. The auto-refill model is a less obvious match for someone seeking a one-time order, and the final quote still depends on clinical review.
For readers considering injections only, compare the complete Strut quote with CoreAge Rx’s starting $99 monthly offer. Ask both providers the same questions so the comparison is about your actual plan.
Common questions
What is the price difference between formats?
Strut advertises $119 monthly for the injection and $99 for a 30-day lozenge supply. Its page says final pricing is determined after consultation.
Are the two formats equivalent?
The same ingredient does not establish equal absorption or clinical effects. Ask the clinician for formulation-specific evidence.
Are visits and shipping included?
Strut’s pricing section says physician consultations and shipping are included. Confirm what applies to your prescribed plan.
Explore Strut Health
See the current offer and decide whether you want to start a consultation.
Visit Strut HealthReader-supported. We may earn a commission when you use our partner links. How we’re funded
Sources & further reading
Sources reviewed October 2026. Provider prices and terms may change.